HICP - Tea, mate and other plant-derived products for infusion (ND) in Latvia
Latvia: HICP - Tea, mate and other plant-derived products for infusion (ND) was 1.88 in 2026. ▼ Falling
Latest (2026)
1.88
Change on year
down 25.1%
World rank
4th
of 27 countries
All-time high
3.55
in 1996
All-time low
1.42
in 2011
Years of data
31
1996–2026
HICP - Tea, mate and other plant-derived products for infusion (ND) in Latvia, 1996–2026
Source: European Central Bank.
Analysis
The most recent figure for hicp - tea, mate and other plant-derived products for infusion (nd) in Latvia is 1.88, measured in 2026.
The figure is down 25.1% on the previous year and down 0.5% over ten years.
Over the whole period, hicp - tea, mate and other plant-derived products for infusion (nd) in Latvia peaked at 3.55 in 1996 and was at its lowest, 1.42, in 2011.
Latvia ranks 4th of 27 countries on this measure, in the top quarter.
The long-run direction has been consistently falling across the 31 years of available data.
HICP - Tea, mate and other plant-derived products for infusion (ND) in Latvia, year by year
| Year | Value | Change |
|---|---|---|
| 1996 | 3.55 | — |
| 1997 | 2.49 | -29.9% |
| 1998 | 2.4 | -3.6% |
| 1999 | 2.65 | +10.4% |
| 2000 | 2.5 | -5.7% |
| 2001 | 2.41 | -3.6% |
| 2002 | 2.36 | -2.1% |
| 2003 | 2.58 | +9.3% |
| 2004 | 2.62 | +1.6% |
| 2005 | 2.31 | -11.8% |
| 2006 | 2.34 | +1.3% |
| 2007 | 2.09 | -10.7% |
| 2008 | 1.79 | -14.4% |
| 2009 | 1.79 | +0.0% |
| 2010 | 2.2 | +22.9% |
| 2011 | 1.42 | -35.5% |
| 2012 | 1.55 | +9.2% |
| 2013 | 1.9 | +22.6% |
| 2014 | 1.69 | -11.1% |
| 2015 | 1.91 | +13.0% |
| 2016 | 1.89 | -1.0% |
| 2017 | 1.83 | -3.2% |
| 2018 | 1.71 | -6.6% |
| 2019 | 1.74 | +1.8% |
| 2020 | 1.98 | +13.8% |
| 2021 | 2.42 | +22.2% |
| 2022 | 2.35 | -2.9% |
| 2023 | 2.48 | +5.5% |
| 2024 | 2.52 | +1.6% |
| 2025 | 2.51 | -0.4% |
| 2026 | 1.88 | -25.1% |
Latvia compared with similar countries
- Latvia's 1.88 is above the median for Europe & Central Asia, which is 0.92, 2.0× the median. (26 countries reporting)
- Latvia's 1.88 is above the median for high income countries, which is 0.92, 2.0× the median. (27 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 2.77 | 2.4 | 3.55 | 4 |
| 2000s | 2.28 | 1.79 | 2.62 | 10 |
| 2010s | 1.78 | 1.42 | 2.2 | 10 |
| 2020s | 2.31 | 1.88 | 2.52 | 7 |
Countries ranked near Latvia
More economy & growth data for Latvia
- Foreign direct investment, net outflows (BoP, current US$), gaps 317.22 million BoP, current US$ (2025)
- Foreign direct investment, net outflows (BoP, current US$), per unit 0.0065 BoP, current US$ per US$ of GDP (2025)
- Foreign direct investment, net outflows (BoP, current US$), per capita 171.67 BoP, current US$ per person (2025)
- Foreign direct investment, net inflows (BoP, current US$), gaps filled 243.70 million BoP, current US$ (2025)
- Foreign direct investment, net inflows (BoP, current US$), annual -83.9 % change on previous year (2025)
- Foreign direct investment, net inflows (BoP, current US$), per unit 0.005 BoP, current US$ per US$ of GDP (2025)
- Foreign direct investment, net inflows (BoP, current US$), per capita 131.89 BoP, current US$ per person (2025)
- Total reserves (includes gold, current US$), annual growth rate 18.65 % change on previous year (2025)
- Total reserves (includes gold, current US$), per unit of GDP 0.1255 includes gold, current US$ per US$ of GDP (2025)
- Total reserves (includes gold, current US$), per capita 3,301 includes gold, current US$ per person (2025)
Frequently asked questions
- What is hicp - tea, mate and other plant-derived products for infusion (nd) in Latvia?
- Hicp - tea, mate and other plant-derived products for infusion (nd) in Latvia was 1.88 in 2026, according to European Central Bank.
- What is the highest hicp - tea, mate and other plant-derived products for infusion (nd) recorded in Latvia?
- The highest recorded value was 3.55 in 1996.
- What is the lowest hicp - tea, mate and other plant-derived products for infusion (nd) recorded in Latvia?
- The lowest recorded value was 1.42 in 2011.
- How does Latvia rank for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Latvia ranks 4th out of 27 countries with data for 2026.
- Is hicp - tea, mate and other plant-derived products for infusion (nd) rising or falling in Latvia?
- Over the last ten years it is down 0.5%. The long-run trend across the full record is falling.
- Where does this Latvia data come from?
- The figures come from European Central Bank, published as part of HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 31 observations, free to reuse under ECB Terms and Conditions (attribution required).